Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics

SAGE POWR Grades

• Value is the dimension where SAGE ranks best; there it ranks ahead of 48.44% of US stocks.
• The strongest trend for SAGE is in Growth, which has been heading down over the past 179 days.
• SAGE ranks lowest in Stability; there it ranks in the 13th percentile.

SAGE Stock Summary

• The ratio of debt to operating expenses for SAGE THERAPEUTICS INC is higher than it is for about only 6.9% of US stocks.
• With a price/sales ratio of 326.56, SAGE THERAPEUTICS INC has a higher such ratio than 98.74% of stocks in our set.
• SAGE's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 7.34% of US stocks.
• If you're looking for stocks that are quantitatively similar to SAGE THERAPEUTICS INC, a group of peers worth examining would be CDXS, MRNS, VERU, APLS, and RMBS.
• SAGE's SEC filings can be seen here. And to visit SAGE THERAPEUTICS INC's official web site, go to www.sagerx.com.

SAGE Valuation Summary

• In comparison to the median Healthcare stock, SAGE's price/earnings ratio is 121.24% lower, now standing at -4.8.
• Over the past 105 months, SAGE's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for SAGE.

SAGE Growth Metrics

The 3 year revenue growth rate now stands at -93.05%.
• Its year over year net income to common stockholders growth rate is now at -176%.
• The 5 year cash and equivalents growth rate now stands at 38.2%.

SAGE's revenue has moved down $1,003,000 over the prior 34 months.

The table below shows SAGE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	7.686	-460.036	-532.784
2022-09-30	6.464	-430.605	-510.35
2022-06-30	6.165	-380.566	-503.198
2022-03-31	6.307	-376.896	-484.183
2021-12-31	6.308	-378.182	-457.892
2021-09-30	1,113.852	730.29	641.715

SAGE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SAGE has a Quality Grade of C, ranking ahead of 62.22% of graded US stocks.
• SAGE's asset turnover comes in at 0.544 -- ranking 73rd of 681 Pharmaceutical Products stocks.
• VTGN, SVRA, and SESN are the stocks whose asset turnover ratios are most correlated with SAGE.

The table below shows SAGE's key quality metrics over time.